100 related articles for article (PubMed ID: 9622382)
1. Relationship between platelet membrane lipid compositions and platelet aggregability in alcoholic liver disease.
Watanabe M; Shiraishi K; Itakura M; Matsuzaki S
Alcohol Clin Exp Res; 1998 May; 22(S3 Pt 1):97S-102S. PubMed ID: 9622382
[TBL] [Abstract][Full Text] [Related]
2. Abnormality in membrane fatty acid compositions of cells measured on erythrocyte in alcoholic liver disease.
Shiraishi K; Matsuzaki S; Itakura M; Ishida H
Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):56A-59A. PubMed ID: 8659691
[TBL] [Abstract][Full Text] [Related]
3. Effects of supplementation with unsaturated fatty acids on plasma and membrane lipid composition and platelet function in patients with cirrhosis and defective aggregation.
Marra F; Riccardi D; Melani L; Spadoni S; Galli C; Fabrizio P; Tosti-Guerra C; Carloni V; Gentilini P; Laffi G
J Hepatol; 1998 Apr; 28(4):654-61. PubMed ID: 9566835
[TBL] [Abstract][Full Text] [Related]
4. Platelet prostaglandin production in alcoholic liver disease.
Barrison IG; Viola L; Murray-Lyon IM
Prostaglandins Leukot Med; 1983 Mar; 10(3):331-44. PubMed ID: 6573693
[TBL] [Abstract][Full Text] [Related]
5. Relationships between serum lipids, platelet membrane fatty acid composition and platelet aggregation in type 2 diabetes mellitus.
Rodier M; Colette C; Crastes de Paulet P; Crastes de Paulet A; Monnier L
Diabete Metab; 1993; 19(6):560-5. PubMed ID: 8026607
[TBL] [Abstract][Full Text] [Related]
6. Platelet aggregation and fatty acid composition of platelets in type 1 diabetes mellitus.
Myrup B; Bregengaard C; Petersen LR; Winther K
Clin Chim Acta; 1991 Dec; 204(1-3):251-61. PubMed ID: 1819468
[TBL] [Abstract][Full Text] [Related]
7. Platelet lipid composition and platelet aggregation in human liver disease.
Owen JS; Hutton RA; Day RC; Bruckdorfer KR; McIntyre N
J Lipid Res; 1981 Mar; 22(3):423-30. PubMed ID: 7240967
[TBL] [Abstract][Full Text] [Related]
8. Fish diet and physical fitness in relation to membrane and serum lipids, prostanoid metabolism and platelet aggregation in female students.
Agren JJ; Pekkarinen H; Litmanen H; Hänninen O
Eur J Appl Physiol Occup Physiol; 1991; 63(5):393-8. PubMed ID: 1773818
[TBL] [Abstract][Full Text] [Related]
9. Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis.
Vinholt PJ; Hvas AM; Nielsen C; Söderström AC; Sprogøe U; Fialla AD; Nybo M
Platelets; 2018 Jul; 29(5):520-527. PubMed ID: 28895774
[TBL] [Abstract][Full Text] [Related]
10. Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma.
De Castro J; Hernández-Hernández A; Rodríguez MC; Sardina JL; Llanillo M; Sánchez-Yagüe J
Platelets; 2007 Feb; 18(1):43-51. PubMed ID: 17365853
[TBL] [Abstract][Full Text] [Related]
11. [Alteration of prostaglandin metabolism in alcoholic liver disease: its association with platelet dysfunction after chronic alcohol ingestion].
Arai M; Okuno F; Ishii H; Hirano Y; Sujita K; Kobayashi T; Takagi T; Maruyama K; Kato S; Tsugu M
Nihon Shokakibyo Gakkai Zasshi; 1989 Feb; 86(2):220-6. PubMed ID: 2526889
[TBL] [Abstract][Full Text] [Related]
12. Platelet thromboxane formation capacity after ethanol withdrawal in chronic alcoholics.
Hillbom M; Neiman J
Haemostasis; 1988; 18(3):170-8. PubMed ID: 3141251
[TBL] [Abstract][Full Text] [Related]
13. Impaired erythrocyte deformability and membrane fluidity in alcoholic liver disease: participation in disturbed hepatic microcirculation.
Shiraishi K; Matsuzaki S; Ishida H; Nakazawa H
Alcohol Alcohol Suppl; 1993; 1A():59-64. PubMed ID: 8141924
[TBL] [Abstract][Full Text] [Related]
14. Alcoholic fatty liver disease and alcoholic liver cirrhosis may be differentiated with mean platelet volume and platelet distribution width.
Lee WS; Kim TY
Platelets; 2010; 21(7):584-5. PubMed ID: 20672909
[No Abstract] [Full Text] [Related]
15. Influence of pantethine on platelet volume, microviscosity, lipid composition and functions in diabetes mellitus with hyperlipidemia.
Hiramatsu K; Nozaki H; Arimori S
Tokai J Exp Clin Med; 1981 Jan; 6(1):49-57. PubMed ID: 7256794
[TBL] [Abstract][Full Text] [Related]
16. Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis.
Pantaleo P; Marra F; Vizzutti F; Spadoni S; Ciabattoni G; Galli C; La Villa G; Gentilini P; Laffi G
Clin Sci (Lond); 2004 Jan; 106(1):27-34. PubMed ID: 12877651
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte membrane lipids and serum selenium in post-viral and alcoholic cirrhosis.
Guarini P; Stanzial AM; Olivieri O; Casaril M; Galvani S; Pantalena M; Corrocher R
Clin Chim Acta; 1998 Feb; 270(2):139-50. PubMed ID: 9544451
[TBL] [Abstract][Full Text] [Related]
18. Improvement of metabolic control and changes of fatty acid composition do not alter platelet aggregability and thromboxane production in type 2 diabetes mellitus.
Ratzmann KP; Schimke E; Beitz A; Hildebrandt R; Taube C
Horm Metab Res Suppl; 1992; 26():103-5. PubMed ID: 1490671
[TBL] [Abstract][Full Text] [Related]
19. Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet.
Kusumoto A; Ishikura Y; Kawashima H; Kiso Y; Takai S; Miyazaki M
Br J Nutr; 2007 Sep; 98(3):626-35. PubMed ID: 17445350
[TBL] [Abstract][Full Text] [Related]
20. Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients.
Véricel E; Colas R; Calzada C; Lê QH; Feugier N; Cugnet C; Vidal H; Laville M; Moulin P; Lagarde M
Thromb Haemost; 2015 Aug; 114(2):289-96. PubMed ID: 25832443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
